Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04780217 |
| Title | A Clinical Study of Intravenous T3011 Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ImmVira Pharma Co. Ltd |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Phoenix | Arizona | 85012 | United States | Details | |
| BRCR Medical Center Inc | Plantation | Florida | 33322 | United States | Details | |
| Prisma Health - Upstate | Greenville | South Carolina | 29601 | United States | Details | |
| Virginia Cancer Specialists | Greenville | South Carolina | 29605 | United States | Details | |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details |